Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | ARK Innovation |
| Investment focus | Equity, World |
| Fund size | GBP 257 m |
| Total expense ratio | 0.75% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Actively managed |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 36.80% |
| Inception/ Listing Date | 12 April 2024 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | ARK Invest International |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
| Revision Company | Deloitte Ireland LLP |
| Fiscal Year End | 1 June |
| Swiss representative | 1741 Fund Solutions AG |
| Swiss paying agent | Tellco AG |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Tesla | 8.48% |
| Space Exploration Techs | 5.86% |
| Tempus AI, Inc. | 5.30% |
| Circle Internet Group | 5.19% |
| Robinhood Markets, Inc. | 5.18% |
| CRISPR Therapeutics | 5.14% |
| Coinbase Global | 4.42% |
| Twist Bioscience | 4.42% |
| 10x Genomics | 4.17% |
| AMD | 3.49% |
| United States | 87.68% |
| Switzerland | 5.14% |
| Canada | 3.94% |
| Cayman Islands | 2.01% |
| Taiwan | 1.23% |
| Other | 0.00% |
| Healthcare | 32.08% |
| Finance | 24.89% |
| Technology | 19.35% |
| Consumer Cyclicals | 8.48% |
| Other | 15.20% |
| YTD | +25.63% |
| 1 month | +8.38% |
| 3 months | +10.95% |
| 6 months | +37.11% |
| 1 year | +6.53% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | +93.80% |
| 2025 | +28.94% |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | 36.80% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | 0.18 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -27.84% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -40.22% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | ARKK | - - | - - | - |
| gettex | EUR | ARXK | - - | - - | - |
| London Stock Exchange | GBX | ARCK | |||
| London Stock Exchange | USD | ARKK | |||
| SIX Swiss Exchange | CHF | ARKK | |||
| XETRA | EUR | ARXK |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 1,313 | 0.40% p.a. | Accumulating | Sampling |
| L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 306 | 0.49% p.a. | Accumulating | Full replication |
| HANetf HAN-GINS Tech Megatrend Equal Weight UCITS ETF | 106 | 0.59% p.a. | Accumulating | Full replication |
| WisdomTree Megatrends UCITS ETF USD | 61 | 0.50% p.a. | Accumulating | Full replication |
| L&G Pharma Breakthrough UCITS ETF | 25 | 0.49% p.a. | Accumulating | Full replication |